Biotech Leaders



Biotech Leaders brings you the knowledge and experience of the best in the business. 

You can also review the Medtech Leaders and Healthtech Leaders


Biotech Leaders

Renee Aguiar-Lucander, CEO, Calliditas Therapeutics

Renee Aguiar-Lucander

CEO
Calliditas Therapeutics
Khatereh Ahmadi, Head of Search and Evaluation Team, European BD&L Hub, MSD

Khatereh Ahmadi

Head of Search and Evaluation Team, European BD&L Hub
MSD
Mehdi Ainouche, Principal, Jeito

Mehdi Ainouche

Principal
Jeito
Michael Altorfer, CEO, Swiss Biotech Association

Michael Altorfer

CEO
Swiss Biotech Association
Madeleine Armstrong, News Editor, Evaluate

Madeleine Armstrong

News Editor
Evaluate
Simon Basham, Head of Cyber & TMT Broking UK, WTW

Simon Basham

Head of Cyber & TMT Broking UK
WTW
Maina Bhaman, Partner, Sofinnova Partners

Maina Bhaman

Partner
Sofinnova Partners
Robin Bhattacherjee, CEO, Actimed Therapeutics

Robin Bhattacherjee

CEO
Actimed Therapeutics
Bernd Boidol, CEO, Proxygen

Bernd Boidol

CEO
Proxygen
Jasper Bos, General Partner, Forbion; CEO, Forbion European Acquisition

Jasper Bos

General Partner, Forbion
CEO, Forbion European Acquisition
Viola Bronsema, CEO, BIO Deutschland

Viola Bronsema

CEO
BIO Deutschland
Roel Bulthuis, Managing Director, INKEF Capital

Roel Bulthuis

Managing Director
INKEF Capital
Matt Cardinal, VP Strategy & Program Leadership, Halloran

Matt Cardinal

VP Strategy & Program Leadership
Halloran
Björn Carlsson, Advisory Board Member, NDA Group

Björn Carlsson

Principal Consultant & Advisory Board Member
NDA Group
John Cassidy, Investment Director Life Sciences & HealthTech, Softbank Vision Fund

John Cassidy

Investment Director Life Sciences & HealthTech
Softbank Vision Fund
Chris Chamberlain, Executive Director Experimental Medicine, AstraZeneca

Chris Chamberlain

Executive Director Experimental Medicine
AstraZeneca
Jean-Philippe Combal, CEO, Vivet Therapeutics

Jean-Philippe Combal

CEO
Vivet Therapeutics
Yuehua Cong, Executive Director, Head of Europe, Simcere Pharmaceutical Group

Yuehua Cong

Executive Director, Head of Europe
Simcere Pharmaceutical Group
Jette Cowan, Head Of Commercial – Pharmaceuticals, RSSL

Jette Cowan

Head Of Commercial – Pharmaceuticals
RSSL
Sarah Cowlishaw, Partner, Covington & Burling

Sarah Cowlishaw

Partner
Covington & Burling
Ian Coyne, Consulting Partner, Coulter Partners

Ian Coyne

Executive Director Global Information & Intelligence
Coulter Partners
David Crome, Managing Director Compliance UK, ProPharma Group

David Crome

Managing Director Compliance UK
ProPharma Group
Maria Dahl, COO and Head of Europe, Innovent Bio

Maria Dahl

COO and Head of Europe
Innovent Bio
Victoria Darbyshire, Equity Analyst, J.P. Morgan

Victoria Darbyshire

Equity Analyst
J.P. Morgan
Nach Dave, Vice President Development Strategy, Premier Research

Nach Dave

Vice President Development Strategy
Premier Research
John Dawson, CEO, Oxford BioMedica

John Dawson

Director
Oxford BioMedica
Lucas de Breed, Founder, August

Lucas de Breed

Founder
August
Ros Deegan, CEO, OMass Therapeutics

Ros Deegan

CEO
OMass Therapeutics
Graham Defries, Partner, Goodwin

Graham Defries

Partner
Goodwin
Christian Dillon​, VP Biology, Phoremost

Christian Dillon

CSO
Phoremost
Suzanne Dilly, CEO, ValiRx

Suzanne Dilly

CEO
ValiRx
Guy Dingley, Partner, Covington & Burling

Guy Dingley

Partner
Covington & Burling
Mark Dorff, Partner, Brown Rudnick

Mark Dorff

Partner
Brown Rudnick
Angela Drew, Director Regulatory Strategy, Premier Consulting

Angela Drew

Director Regulatory Strategy
Premier Consulting
Abie Ekangaki, Vice President, Statistical Consulting, Premier Research

Abie Ekangaki

Vice President, Statistical Consulting
Premier Research
Beth Fordham-Meier, VP Business Development, Cello Health BioConsulting 300x

Beth Fordham-Meier

VP, Business Development, BioConsulting
Lumanity
Jason Foster, CEO, Ori Biotech

Jason Foster

CEO
Ori Biotech
Hayley French, former CEO, Apitope

Hayley French

Investor
Vesalius Biocapital Partners
Lala Gregorek, Healthcare Analyst, Trinity Delta

Lala Gregorek

Healthcare Analyst
Trinity Delta
Franc Gregori, Analyst, Trinity Delta

Franc Gregori

Analyst
Trinity Delta
Andrew Hack, Managing Director, Bain Capital Life Sciences

Andrew Hack

Managing Director
Bain Capital Life Sciences
James Halstead, Partner, Covington & Burling

James Halstead

Partner
Covington & Burling
Sofia Håkansson Buch, VP Stem Cell CMC & Manufacturing, Novo Nordisk

Sofia Håkansson Buch

VP Cell Therapy CMC
Novo Nordisk
Alex Hamilton, Partner, Syncona

Alex Hamilton

Partner
Syncona
Deborah Harland, Partner, SR One

Deborah Harland

Venture Partner
SROne
Steven Harris, Chairman, CS Pharmaceuticals

Steven Harris

Chairman
CS Pharmaceuticals
Andrew Harrow, Partner, Goodwin

Andrew Harrow

Partner
Goodwin
Bill Haynes, Head of Novo Nordisk Research Centre Oxford, Novo Nordisk

Bill Haynes

Head of Novo Nordisk Research Centre Oxford
Novo Nordisk
Brian Heaphy, SVP, Head of Corporate Development, Strategy & Business Development, BMS

Brian Heaphy

SVP, Corporate Development
BMS
Andrew Hill, Product Innovation Lead, Willis Towers Watson

Andrew Hill

Product Innovation Lead
WTW
Regina Hodits, Managing Partner, Wellington Partners

Regina Hodits

Managing Partner
Wellington Partners
Ben Hohn, Principal - Pharmaceuticals & Biotech, Emerging Pharma Lead, ZS Associates

Ben Hohn

Principal - Pharmaceuticals & Biotech, Emerging Pharma Lead
ZS Associates
Asaf Homossany, Senior Managing Director - EMEA, Nasdaq

Asaf Homossany

Senior Managing Director - EMEA
Nasdaq
Anne Horgan, Partner, Cambridge Innovation Capital

Anne Horgan

Partner
Cambridge Innovation Capital
Patrick Hughes, Director, Advisory Services EMEA, Nasdaq

Patrick Hughes

Director, Advisory Services EMEA
Nasdaq
Sofia Ioannidou, Partner, Andera Partners

Sofia Ioannidou

Partner
Andera Partners
Catherine Isted, CFO, ReNeuron

Catherine Isted

CFO
ReNeuron
Pierre-Louis Joffrin, CDO, Mogrify

Pierre-Louis Joffrin

CDO
Mogrify
Fredrik Johansson, CFO, Calliditas Therapeutics

Fredrik Johansson

CFO
Calliditas Therapeutics
Markus Kalousek, Global Head Search & Evaluation, Novartis

Markus Kalousek

Global Head Search & Evaluation
Novartis
Tahera Kan, VP Transactions, Johnson & Johnson Innovation EMEA

Tahera Kan

VP Transactions, Johnson & Johnson Innovation EMEA
Johnson & Johnson
Maya Khurana, Health and Life Sciences Director, Oliver Wyman

Maya Khurana

Health and Life Sciences Director
Oliver Wyman
Sven Kili, CEO, Antion

Sven Kili

CEO
Antion
Dima Kuzmin, Managing Director, 4BIO Capital

Dima Kuzmin

Managing Director
4BIO Capital
Werner Lanthaler, CEO, Evotec

Werner Lanthaler

CEO
Evotec
Stephanie Leouzon, Partner, Torreya

Stephanie Léouzon

Partner
Torreya
Marta Helena Lesko, Head of BD Enabling Technologies, Merck KGaA

Marta Helena Lesko

Head of BD Enabling Technologies
Merck KGaA
Wen Hwa Lee, CEO and Chief Scientist, Action Against AMD (Hehim)

Wen Hwa Lee (He/him)

CEO and Chief Scientist
Action Against AMD
Peter Llewellyn-Davies, CEO, APEIRON

Peter Llewellyn-Davies

CEO
invIOs
Tim Luker, VP Venture Science, Corporate BD, Eli Lilly

Tim Luker

VP Venture Science, Corporate BD
Eli Lilly
Nanna Lüneborg, General Partner, Forbion

Nanna Lüneborg

General Partner
Forbion
Priya Mande, CEO, PsiOxus Therapeutics

Priya Mande

CEO
PsiOxus Therapeutics
Guy Martin, Deputy Editor, Pharma Letter

Guy Martin

Deputy Editor
Pharma Letter
Anton Mat, Director of Business Development, ISA Pharmaceuticals

Anton Mat

Director of Business Development
ISA Pharmaceuticals
Giuseppe Mazza, CEO, Engitix Therapeutics

Giuseppe Mazza

CEO
Engitix Therapeutics
Robbie McLaren, Partner and Vice Chair of the Global Life Sciences Practice, Latham & Watkins

Robbie McLaren

Partner and Vice Chair of the Global Life Sciences Practice
Latham & Watkins
Anita Meiklejohn, Principal, Fish & Richardson

Anita Meiklejohn

Principal
Fish & Richardson
Jason Mellad, CEO, Start Codon

Jason Mellad

CEO
Start Codon
Lisa Melton, Senior News Editor, Nature Biotechnology

Lisa Melton

Senior News Editor
Nature Biotechnology
Piers Morgan, CEO, Cellcentric

Piers Morgan

CFO
Cellcentric
Tim Morris, COOCFO, Humanigen

Tim Morris

COO/CFO
Humanigen
Rachel Moss, Partner, McKinsey

Rachel Moss

Partner
McKinsey
Jukka Muhonen, Global BD & Alliances, Orion Pharma

Jukka Muhonen

Global BD & Alliances
Orion Pharma
Matthias Müllenbeck, SVP, Head Global BD & Alliance Management, Merck KGaA

Matthias Müllenbeck

, SVP, Head Global BD & Alliance Management
Merck KGaA
Tej Panesar, Investment Director, Life Sciences, British Patient Capital

Tej Panesar

Investment Director, Life Sciences
British Patient Capital
Francis Pang, VP Global Market Access, Orchard Therapeutics

Francis Pang

VP Global Market Access
Orchard Therapeutics
Pierluigi Paracchi, CEO, Genenta Biosciences

Pierluigi Paracchi

CEO & Co-founder
Genenta Science
Nick Pattinson, Head of Product, Automata

Nick Pattinson

Head of Product
Automata
Morag Peberdy, Of Counsel, Covington & Burling

Morag Peberdy

Of Counsel
Covington & Burling
Elisa Petris, Partner, Syncona

Elisa Petris

Partner
Syncona
Martin Pfister, Investment Manager, High-Tech Gründerfonds

Martin Pfister

Principal
HTGF
Jim Polson, Managing Director, FTI Consulting

Jim Polson

Managing Director
FTI Consulting
Rebecca Pope (sheher), UK Digital & Data Science Innovation Lead, Roche

Rebecca Pope (she/her)

UK Digital & Data Science Innovation Lead
Roche Products
Steven Powell, CEO, eTheRNA immunotherapies

Steven Powell

CEO
eTheRNA immunotherapies
Cody Powers, Principal - Portfolio & Pipeline, ZS Associates

Cody Powers

Principal - Portfolio & Pipeline
ZS Associates
Marc Ramis Castelltort, CEO, Rejuversen 300x

Marc Ramis Castelltort

Venture Partner
Chasing Science
Tara Raveendran, Head of Healthcare & Life Sciences Research, Polar Capital

Tara Raveendran

Head of Healthcare & Life Sciences Research
Polar Capital
Brad Robling, VP Corporate Business Development, Eli Lilly

Brad Robling

VP, Lilly Ventures, Corporate BD
Eli Lilly
Andrew Roddam, CEO, Our Future Health

Andrew Roddam

CEO
Our Future Health
Kieran Rooney, VP, Strategic Alliances and Licensing, Amryt Pharma

Kieran Rooney

VP, Strategic Alliances and Licensing
Amryt Pharma
Chris Rowe, Innovation Lead, Innovate UK

Chris Rowe

Innovation Lead
Innovate UK
John Rudy, Member, Mintz

John Rudy

Member
Mintz
Igor Rudychev, VP Enterprise Analytics, Horizon Therapeutics

Igor Rudychev

VP Enterprise Analytics
Horizon Therapeutics
Arthur Sands, CEO, Nurix Inc.

Arthur Sands

CEO
Nurix Inc.
Ed Saltzman, Executive Chairman at Cello Health BioConsulting

Ed Saltzman

Head, Biotech Strategy
Lumanity
Isabella Schidrich, Senior Managing Director, Nasdaq

Isabella Schidrich

Senior Managing Director
Nasdaq
Sara Secall, Investment Director & Partner, Inveready Asset Management 300x

Sara Secall

Partner
Inveready
Graziano Seghezzi, Managing Partner, Sofinnova

Graziano Seghezzi

Managing Partner
Sofinnova
Nigel Sheail, Global Head of M&A and BD&L, Novartis

Nigel Sheail

Global Head of M&A and BD&L
Novartis
Tom Shepherd, CEO, Captor Therapeutics

Tom Shepherd

CEO
Captor Therapeutics
João Siffert, CEO & President, Design Therapeutics

João Siffert

CEO & President
Design Therapeutics
Stephanie Sirota, Partner and CBO, RTW Investments

Stephanie Sirota

Partner and CBO
RTW Investments
Ulrica Slåne Bjerke, CIO, Arctic Aurora LifeScience

Ulrica Slåne Bjerke

CIO
Arctic Aurora LifeScience
Rhoda Steel, Head of Community Impact, Johnson & Johnson UK

Rhoda Steel

Head of Community Impact
Johnson & Johnson UK
Johan Strömquist, CEO, NDA Group

Johan Strömquist

CEO
NDA Group
Anette Steenberg, CEO, Medicon Valley Alliance

Anette Steenberg

CEO
Medicon Valley Alliance
Nicki Thompson, CEO, Amphista Therapeutics

Nicki Thompson

CEO
Amphista Therapeutics
Andrew Udell, President, North America, Calliditas Therapeutics

Andrew Udell

President, North America
Calliditas Therapeutics
Erik van den Berg, CEO, AM Pharma

Erik van den Berg

CEO
AM Pharma
Sally Van Kooten, VP Commercial Strategy, Kalvista

Sally van Kooten

VP Commercial Strategy
KalVista Pharmaceuticals
Edward van Wezel, Managing Partner, BGV

Edward van Wezel

Managing Partner
BGV
Bonnie Van Wilgenburg, Principal, Monograph Capital Partners

Bonnie Van Wilgenburg

Principal
Monograph Capital Partners
Valerie Vanhooren, CEO, ONA Therapeutics

Valerie Vanhooren

CEO & Co-Founder
ONA Therapeutics
Pnina Weitz, Global Head of VC Business Development & Relationship Management, Lonza

Pnina Weitz

Global Head of VC Business Development & Relationship Management
Lonza
Nicklas Westerholm, CEO, Egetis Therapeutics

Nicklas Westerholm

CEO
Egetis Therapeutics
Anna Williamson, Executive Director, Roche Pharma Partnering

Anna Williamson

Executive Director
Roche Pharma Partnering
Donald Xu, Managing Partner, Lynx Financial

Donald Xu

Managing Director
Lynx Capital
Alexandra Zemp, Partner, McKinsey

Alexandra Zemp

Partner
McKinsey
Klaas Zuideveld, CEO, Versameb

Klaas Zuideveld

CEO
Versameb
Marcel Zwaal, CEO, Gadeta

Marcel Zwaal

CEO
Gadeta
DOWNLOAD BROCHURE